A Randomised, Double-blind, Vehicle-Controlled, Phase IIb Study to Assess the Efficacy and Safety of Topically Applied DS107 Cream to Adults With Mild to Moderate Atopic Dermatitis
Phase of Trial: Phase II
Latest Information Update: 10 Jan 2018
At a glance
- Drugs Dihomo-gamma linolenic acid (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- Acronyms ADvantage
- Sponsors DS Biopharma
- 04 Jan 2018 Planned End Date changed from 1 Oct 2017 to 1 Jul 2018.
- 04 Jan 2018 Planned primary completion date changed from 1 Jun 2017 to 1 Mar 2018.
- 06 Jan 2017 Status changed from not yet recruiting to recruiting, as per a DS Biopharma media release.